Deerfield Management Company, L.P. (Series C) Integra Lifesciences Holdings Corp Transaction History

Deerfield Management Company, L.P. (Series C)

  • $5.38 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$23.14 - $34.72 $126,298 - $189,501
-5,458 Reduced 0.37%
1,467,632 $42.8 Million
Q1 2024

May 15, 2024
BUY
$33.4 - $45.2 $11.5 Million - $15.6 Million
344,091 Added 30.48%
1,473,090 $52.2 Million
Q4 2023

Feb 14, 2024
BUY
$34.21 - $44.59 $74,304 - $96,849
2,172 Added 0.19%
1,128,999 $49.2 Million
Q3 2023

Nov 14, 2023
BUY
$37.8 - $45.97 $42.6 Million - $51.8 Million
1,126,827 New
1,126,827 $43 Million

Others Institutions Holding IART

# of Institutions
241
Shares Held
75.3M
Call Options Held
585K
Put Options Held
21.3K
View Full List

About INTEGRA LIFESCIENCES HOLDINGS CORP

IART Quotes by TradingView
  • Ticker IART
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,518,200
  • Market Cap $1.85B
  • Description
  • Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...
More about IART
Track This Portfolio

Track Deerfield Management Company, L.P. (Series C) Portfolio

Follow Deerfield Management Company, L.P. (Series C) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email